Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/21/26 16:05 | 9/18/26 | NBP | Health | Drug | Pharmaceutical Preparations | Dennis Phillip Andrew | MD | O | Chief Me | S.d | -6 | 0.7100 | 0 | -8 | -5 | 173 | D | ||||||||||||||
9/11/26 16:30 | 9/9/26 | NBP | Health | Drug | Pharmaceutical Preparations | Cao Sean Wuxiong | MD | O | Chief Bu | S | -80 | 0.7400 | 0 | -108 | -29 | 266 | D | ||||||||||||||
9/1/26 18:00 | 8/31/26 | NBP | Health | Drug | Pharmaceutical Preparations | Xu Cong Claire | MD | O | EVP,Clin | S.d | -3 | 0.7900 | 0 | -3 | -1 | 304 | D | ||||||||||||||
7/7/26 19:50 | 7/6/26 | NBP | Health | Drug | Pharmaceutical Preparations | Xu Cong Claire | MD | O | SVP,Clin | S.d | -4 | 0.8900 | 0 | -4 | -1 | 298 | D | ||||||||||||||
6/22/26 17:23 | 6/18/26 | NBP | Health | Drug | Pharmaceutical Preparations | Dennis Phillip Andrew | MD | O | Chief Me | S.d | -6 | 0.6600 | 0 | -8 | -5 | 158 | D | ||||||||||||||
6/2/26 18:46 | 6/1/26 | NBP | Health | Drug | Pharmaceutical Preparations | Xu Cong Claire | MD | O | SVP,Clin | S.d | -14 | 3.94 | 0 | -3 | -1 | 290 | D | ||||||||||||||
5/18/26 16:05 | 5/14/26 | NBP | Health | Drug | Pharmaceutical Preparations | Cao Sean Wuxiong | MD | DO | See Rema | S | -43 | 1.99 | 0 | -21 | -38 | 35 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |